Skip to main content
. 2021 May 29;42(12):3833–3844. doi: 10.1002/hbm.25468

TABLE 1.

Baseline measures in real and sham treatment groups

Measures Real (n = 20) Sham (n = 17) t/X 2 p
Mean ± SD Mean ± SD
Demographic data
Age (years) 27.75 ± 1.58 27.65 ± 1.73 .044 a .763
Sex (male/female) 15/5 12/5 >.99 b
Education (years) 14.05 ± 0.50 12.82 ± 0.516 1.700 a .098
Illness duration (years) 5.81 ± 0.90 4.24 ± 0.88 1.241 a .223
Medication (yes/no) 14/6 14/3 .462 b
No. drug types 1.5 ± 1.40 2.2 ± 1.67 1.34 .19
Symptom estimations
Y‐BOCS total (primary outcome) 21.00 ± 1.13 20.29 ± 1.25 0.420 a .677
Y‐BOCS obsessive 11.60 ± 0.87 10.94 ± 1.04 0.489 a .628
Y‐BOCS compulsive 9.40 ± 1.01 9.35 ± 1.23 0.030 a .976
HARS 8.05 ± 0.75 6.35 ± 0.73 1.616 a .115
HDRS 6.85 ± 0.89 5.94 ± 0.67 0.792 a .434
Neuropsychological tests
TMT A (second) 53.57 ± 4.28 59.69 ± 5.93 0.849 c .402
TMT B (second) 98.77 ± 4.46 114.90 ± 11.18 1.393 c .173
SCWT (second) 10.93 ± 1.53 8.75 ± 1.35 1.065 d .295
DS forward 7.79 ± 0.12 7.88 ± 0.08 0.617 c .542
DS backward 5.84 ± 0.23 6.18 ± 0.27 0.935 c .356
Target information c
MNI coordinate X 8.33 ± 3.18 9.00 ± 2.35 0.66 d .52
MNI coordinate Y 12.33 ± 7.12 9.79 ± 7.08 1.00 d .32
MNI coordinate Z 59.50 ± 4.96 62.50 ± 4.49 1.77 d .09
zFC to STN 0.11 ± 0.09 0.10 ± 0.08 0.21 d .84

Abbreviations: DS, Digit Span; HARS, Hamilton Anxiety Rating Scale; HDRS, Hamilton Depression Rating Scale; MNI, Montreal Neurological Institute; SCWT, Stroop Color Word Test; STN, subthalamic nucleus; TMT, Trail Making Test; Y‐BOCS, Yale‐Brown Obsessive Compulsive Scale; zFC, Fisher's z transformed functional connectivity.

a

Paired t test.

b

Fisher's exact test.

c

One patient in the real group did not compete these tests.

d

The data were from 18 and 14 patients in the real group and sham group, respectively.